RP-A501

· Rocket Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP-A501, covering 2025-10-07 to 2025-10-07. Get the full timeline:

Most recent: Clinical Trial Update: A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease [Phase 2]